MCM
ELV icon

Matarin Capital Management’s Elevance Health ELV Stock Holding History

Matarin Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,056
Closed -$3.64M – 216
2019
Q4 		$3.64M Sell
12,056
-7,573
-39% -$2.08M 0.35% 131
2019
Q3 		$4.71M Sell
19,629
-34
-0.2% -$9.32K 0.36% 103
2019
Q2 		$5.55M Hold
19,663
– – 0.4% 95
2019
Q1 		$5.64M Sell
19,663
-13
-0.1% -$3.76K 0.41% 92
2018
Q4 		$5.17M Sell
19,676
-2,609
-12% -$717K 0.42% 86
2018
Q3 		$6.11M Buy
22,285
+4,923
+28% +$1.28M 0.39% 92
2018
Q2 		$4.13M Sell
17,362
-3,442
-17% -$797K 0.3% 114
2018
Q1 		$4.57M Sell
20,804
-4,111
-17% -$966K 0.34% 105
2017
Q4 		$5.61M Hold
24,915
– – 0.44% 84
2017
Q3 		$4.73M Sell
24,915
-7,284
-23% -$1.39M 0.4% 100
2017
Q2 		$6.06M Buy
32,199
+4,286
+15% +$770K 0.56% 75
2017
Q1 		$4.62M Sell
27,913
-1,118
-4% -$178K 0.45% 82
2016
Q4 		$4.17M Sell
29,031
-13,594
-32% -$1.82M 0.47% 77
2016
Q3 		$5.34M Buy
42,625
+13,858
+48% +$1.79M 0.59% 79
2016
Q2 		$3.78M Buy
28,767
+4,321
+18% +$591K 0.51% 89
2016
Q1 		$3.4M Sell
24,446
-1,694
-6% -$226K 0.47% 92
2015
Q4 		$3.64M Buy
26,140
+17,443
+201% +$2.4M 0.55% 86
2015
Q3 		$1.22M Sell
8,697
-4,230
-33% -$636K 0.25% 123
2015
Q2 		$2.12M Sell
12,927
-102
-0.8% -$16.3K 0.61% 72
2015
Q1 		$2.01M Buy
+13,029
New +$1.86M 0.61% 73
2014
Q4 		– Sell
-9,334
Closed -$1.12M – 157
2014
Q3 		$1.12M Buy
9,334
+7,244
+347% +$831K 0.51% 93
2014
Q2 		$225K Buy
+2,090
New +$215K 0.1% 160
2013
Q4 		– Sell
-3,018
Closed -$252K – 134
2013
Q3 		$252K Buy
+3,018
New +$259K 0.21% 147

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Matarin Capital Management's ELV Position: Q1 2020 in Review

Matarin Capital Management sold out of Elevance Health (ELV) in Q1 2020, closing a stake of 12,056 shares — an estimated $3.64M sold.

Matarin Capital Management first reported a position in ELV in Q3 2013 and held it in 23 quarters. The position peaked at $6.11M in Q3 2018. 1,053 funds tracked by Wall St. Rank hold ELV as of Q1 2020.

  • Matarin Capital Management reported no remaining Elevance Health position as of Q1 2020 after selling out during the quarter.
  • Matarin Capital Management sold 12,056 Elevance Health shares in Q1 2020, an estimated $3.64M.
  • Matarin Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 23 quarters.
  • Matarin Capital Management's Elevance Health position peaked at $6.11M in Q3 2018.
  • 1,053 funds tracked by Wall St. Rank held Elevance Health as of Q1 2020.

Based on Matarin Capital Management's 13F filing for Q1 2020, filed 27 Apr 2020.